Evidence map›Paper›PMID 40469480›Full record

ArticleEnvironmental science and ecotechnology2025

A life cycle risk assessment of nanopesticides in freshwater.

Mingyan Ke, Keshuo Zhang, Andrea L Hicks, Fan Wu, Jing You

Abstract read
In one paragraph

Article in Environmental science and ecotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mingyan KeCollege of Environment and Climate, Guangdong Provincial Key Laboratory of Environmental Pollution and Health, Jinan University, Guangzhou, 511443, China.
Keshuo ZhangCollege of Environment and Climate, Guangdong Provincial Key Laboratory of Environmental Pollution and Health, Jinan University, Guangzhou, 511443, China.
Andrea L HicksDepartment of Civil and Environmental Engineering, University of Wisconsin-Madison, Madison, WI, 53706, USA.
Fan WuCollege of Environment and Climate, Guangdong Provincial Key Laboratory of Environmental Pollution and Health, Jinan University, Guangzhou, 511443, China.
Jing YouCollege of Environment and Climate, Guangdong Provincial Key Laboratory of Environmental Pollution and Health, Jinan University, Guangzhou, 511443, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conventional ecological risk assessments prioritize downstream anthropogenic impacts, overlooking risks arising from upstream processes involving highly hazardous substances and indirect emissions. This narrow focus obscures high-risk hotspots and renders traditional methodologies ill-suited for evaluating novel chemical entities. Nanopesticides, designed for targeted delivery of pesticidal active ingredients, are increasingly deployed to enhance efficiency, yet their altered environmental fate and transport dynamics may reshape end-of-life risks while their full lifecycle impacts remain uncharacterized. Here, we address this gap using imidacloprid (IMI) and its nano-encapsulated variant (nano-IMI) as case studies. By applying life cycle assessment and integrating the USEtox ecotoxicity model with the nano-specific SimpleBox4Nano framework, we quantify "cradle-to-gate" environmental impacts and derive substance-specific ecotoxicity metrics, enabling systematic characterization of end-of-life risks associated with these formulations. Production-stage ecological risks of nano-IMI (4.63 × 10

Indexed as

Characterization factorImpact scoreLife cycle assessmentNanopesticideRisk assessment

Identifiers

PMID40469480
PMCPMC12136839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.